Allogeneic anti-CD7 CAR T-cell therapy(Nanjing Bioheng Biotech))

No patents found under this name

Patent documents usually refer to a drug by its chemical name or development code rather than its generic name, and applications are only published about 18 months after filing — so a newer drug may not appear here yet.